Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSPECT: Prednisone for Non-specific Pleuritis
NCT07039019Phase 1Recruiting
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- May 2025
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of prednisone in Pleuritis (2 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoints: Number of patients screened at 6 months, Number of patients enrolled at 6 months and 1 more. Started May 2025; status: recruiting.
02
Drugs
prednisone
03
Conditions
Pleuritis
Beyond the preview
Go deeper on NCT07039019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07039019.